Rajeev Saggar - Jan 11, 2024 Form 4 Insider Report for Liquidia Corp (LQDA)

Role
Chief Medical Officer
Signature
/s/ Dr. Rajeev Saggar
Stock symbol
LQDA
Transactions as of
Jan 11, 2024
Transactions value $
$0
Form type
4
Date filed
1/16/2024, 05:03 PM
Previous filing
Dec 18, 2023
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LQDA Common Stock Award $0 +56.5K +34.43% $0.00 221K Jan 11, 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LQDA Performance Stock Units Award $0 +56.5K $0.00 56.5K Jan 11, 2024 Common Stock 56.5K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 25% of the RSUs shall vest on January 11, 2025 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter.
F3 Includes (i) 46,052 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023 and (iii) 1,189 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
F4 Each performance stock unit ("PSU") converts into one share of the Issuer's common stock.
F5 On January 11, 2024, the Reporting Person was granted 56,492 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer.